Streetbeat News

Earnings

SFL

SND

As of Feb. 27, 2024, Smart Sand, Inc. (SND), Permian Resources Corporation (PR), and SFL Corporation Ltd. (SFL) are identified as overbought energy stocks with RSI values above 70, indicating potential short-term performance concerns. SND filed for a mixed shelf of up to $200 million, PR received a price target increase from Truist Securities, and SFL posted upbeat quarterly results.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 1:21 pm

DNLI

Denali Therapeutics announced that its FY24 operating expenses will be less than or equal to those of 2023. The company also expects its cash runway to extend into 2028, indicating a strong financial position and efficient cost management.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:21 pm

DPZ

Domino's Pizza Inc (NYSE:DPZ) reported Q4 earnings surpassing expectations with an EPS of $4.48 against a consensus of $4.38, and sales of $1.40 billion. Despite a slight miss on sales consensus, the company announced a 25% dividend increase to $1.51 and a $1 billion stock buyback. Analysts from JP Morgan, Oppenheimer, and Argus Research adjusted their price targets and ratings, reflecting a positive outlook on DPZ's performance.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 1:20 pm

DNLI

Denali Therapeutics reported a Q4 2023 GAAP EPS of $(0.86), missing the consensus estimate of $(0.81) by 6.17%.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:18 pm

VYNE

VYNE Therapeutics announced it will present positive safety and efficacy data for its novel BET inhibitor, VYN201, at the 2024 Global Vitiligo Foundation Annual Scientific Symposium on March 7, 2024. The data comes from a Phase 1b trial.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:14 pm

CROX

FTI

ROKU

USAC

Notable insider sales were reported for TechnipFMC, USA Compression Partners, Crocs, and Roku. These sales come after each company reported positive financial results. Insider sales can indicate various strategic decisions but are not the sole factor for investment decisions.

Portfolio Pulse from Avi Kapoor

February 27, 2024 | 1:09 pm

CMLS

Cumulus Media (CMLS) reported a Q4 adjusted EPS of $(1.98), missing the $(0.59) estimate by 235.59%, with sales of $221.30M beating the $220.07M estimate by 0.56%. This represents an 11.93% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:09 pm

PTLO

Portillo's has outlined its long-term growth expectations, projecting restaurant unit growth of 12% to 15%, total revenue growth in the mid-teens, and adjusted EBITDA growth in the low teens.

Portfolio Pulse from Benzinga Newsdesk

February 27, 2024 | 1:06 pm

CARG

EVER

PUBM

In Tuesday's pre-market session, several communication services stocks showed significant movement. PubMatic, Snail, EverQuote, and others experienced gains, with PubMatic leading at a 37.8% increase following their Q4 earnings report. Conversely, CarGurus, Motorsport Games, and other stocks faced declines, with CarGurus dropping 12.1% after their Q4 earnings release.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 1:06 pm

JANX

MDRX

NRXP

TMDX

VKTX

In Tuesday's pre-market session, health care stocks saw significant movements. Janux Therapeutics and Viking Therapeutics led the gainers with over 90% increases in their stock prices, while NRX Pharmaceuticals and Veradigm were among the top losers, experiencing over 20% declines. Notably, TransMedics, Ligand Pharmaceuticals, and Hims & Hers Health reported their Q4 earnings, influencing their stock movements.

Portfolio Pulse from Benzinga Insights

February 27, 2024 | 1:06 pm